Open enrollment for the 2014 state and federal health insurance exchanges will end this month, but various findings contest their anticipated success.
Open enrollment for the 2014 state and federal health insurance exchanges will end this month, but various findings contest their anticipated success.
One study, published by the National Center for Public Policy Research (NCPPR), determined that despite early administrative claims, the exchanges did not yield more choice nor did they lower prices. David Hogberg, PhD, senior fellow for health care policy at NCPPR, compared the insurance policy options of a 27-year-old single individual and of a 57-year-old couple. He said that in both cases, private websites such as eHealthinsurance.com and Finder.healthcare.gov had significantly more choices than did the exchanges. Dr Hogberg also noted that private policy options cost less than the even the lowest-priced policy options on the exchanges.
“A 27-year-old male who paid full price on an exchange (ie, he did not receive a subsidy) had, on average, 32 cheaper policies to choose from on eHealth and 38 on Finder. For a 27-year-old female, eHealth had, on average, 18 cheaper polices and Finder had 20 cheaper policies compared to the exchanges,” he said. “A 57-year-old couple that received no subsidy on the exchange could have found cheaper polices in all of the cities examined. The average number of cheaper polices on eHealth was 29 and for Finder it was 28. There were cheaper policies on eHealth and Finder in every city for a 57-year-old couple when compared to the exchanges. Atlanta, Georgia had the greatest number of policies that cost less than the lowest-price exchange policy. There were 56 polices that cost less on eHealth and 112 on Finder.”
Cities in 13 states were examined, including: Alaska, Arkansas, Arizona, California, Colorado, Connecticut, Florida, Georgia, Kentucky, Montana, Nevada, Virginia, and Wisconsin.
In addition to the less-than-stellar exchange outcomes, another recent report from Avalere Health suggests that while more than 8.9 million people were eligible for a subsidy for Medicaid under the Affordable Care Act (ACA), the actual number of those who signed up for coverage is estimated at between 2.4 and 3.5 million.
While Medicaid enrollment does not end on Match 31, the group estimates that only 5 million Americans are likely to join the program this year.
“One major goal of the [ACA] was to reduce the number of uninsured, and Medicaid expansion is a key part of that,” said Caroline Pearson, vice president of Avalere. “These numbers show that the administration has a ways to go toward its enrollment goal and will need to conduct sustained outreach and education efforts to draw more people into coverage throughout the year.”
Around the Web
ObamaCare Exchanges: Less Choice, Higher Prices [NCPRR]
Lower Medicaid Signups Seen in Health Law Study
Fewer than 2 million Signed up for Medicaid Under the Health Law, Report Says
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More